UnitedHealth Group (NYSE:UNH) Price Target Raised to $617.00
UnitedHealth Group (NYSE:UNH) Price Target Raised to $617.00
UnitedHealth Group (NYSE:UNH – Get Rating) had its price objective increased by Deutsche Bank Aktiengesellschaft from $615.00 to $617.00 in a report released on Tuesday, The Fly reports. They currently have a buy rating on the healthcare conglomerate's stock.
据The Fly报道，德意志银行周二发布的一份报告将UnitedHealth Group(纽约证券交易所代码：UNH-GET评级)的目标价从615.00美元上调至617.00美元。他们目前对这家医疗保健集团的股票给予买入评级。
A number of other equities analysts have also recently issued reports on the stock. SVB Leerink dropped their price objective on shares of UnitedHealth Group from $625.00 to $618.00 and set an outperform rating for the company in a research note on Monday, October 17th. Loop Capital upped their target price on shares of UnitedHealth Group from $575.00 to $590.00 in a report on Tuesday, January 17th. Credit Suisse Group upped their target price on shares of UnitedHealth Group from $590.00 to $610.00 and gave the stock an outperform rating in a report on Wednesday, December 7th. Morgan Stanley reaffirmed an overweight rating and issued a $587.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 23rd. Finally, Raymond James lowered shares of UnitedHealth Group from a strong-buy rating to an outperform rating and set a $615.00 target price on the stock. in a report on Monday, November 21st. Three investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $599.39.
其他一些股票分析师最近也发布了有关该股的报告。10月17日，SVB Leerink在一份研究报告中将UnitedHealth Group的股票目标价从625.00美元下调至618.00美元，并为该公司设定了表现优于大盘的评级。在1月17日星期二的一份报告中，loop Capital将UnitedHealth Group的目标股价从575.00美元上调至590.00美元。瑞士信贷集团将UnitedHealth Group的股票目标价从590.00美元上调至610.00美元，并在12月7日周三的一份报告中给予该股表现优于大盘的评级。摩根士丹利在11月23日周三的一份报告中重申了增持评级，并对联合健康集团的股票发布了587.00美元的目标价。最后，雷蒙德·詹姆斯将UnitedHealth Group的股票评级从强力买入下调至表现优于大盘，并为该股设定了615.00美元的目标价。在11月21日星期一的一份报告中。三位投资分析师对该股的评级为持有，12位分析师给出了买入评级，一位分析师给出了强烈的买入评级。根据MarketBeat的数据，该股的平均评级为适度买入，共识目标价为599.39美元。
UnitedHealth Group Price Performance
UnitedHealth Group价格表现
NYSE:UNH opened at $486.05 on Tuesday. The stock has a market cap of $454.14 billion, a P/E ratio of 22.94, a PEG ratio of 1.38 and a beta of 0.73. UnitedHealth Group has a one year low of $445.73 and a one year high of $558.10. The company has a fifty day moving average price of $517.61 and a 200 day moving average price of $523.64. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.77 and a quick ratio of 0.82.
纽约证券交易所：UNH周二开盘报486.05美元。该股市值为4541.4亿美元，市盈率为22.94倍，市盈率为1.38倍，贝塔系数为0.73倍。UnitedHealth Group的一年低点为445.73美元，一年高位为558.10美元。该公司的50日移动平均价为517.61美元，200日移动平均价为523.64美元。该公司的债务权益比为0.67，流动比率为0.77，速动比率为0.82。
UnitedHealth Group Announces Dividend
UnitedHealth Group宣布分红
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 13th. Stockholders of record on Monday, December 5th were paid a $1.65 dividend. This represents a $6.60 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend was Friday, December 2nd. UnitedHealth Group's dividend payout ratio (DPR) is presently 31.15%.
该公司最近还宣布了季度股息，股息于12月13日(星期二)支付。12月5日(星期一)登记在册的股东获得了1.65美元的股息。这意味着年化股息为6.60美元，股息收益率为1.36%。本次股息除息日期为12月2日星期五。UnitedHealth Group的股息支付率(DPR)目前为31.15%。
Insider Activity at UnitedHealth Group
UnitedHealth Group的内部活动
In related news, EVP Erin Mcsweeney sold 450 shares of the stock in a transaction that occurred on Wednesday, December 7th. The shares were sold at an average price of $542.30, for a total value of $244,035.00. Following the sale, the executive vice president now directly owns 8,736 shares in the company, valued at approximately $4,737,532.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.40% of the stock is currently owned by corporate insiders.
在相关新闻中，执行副总裁Erin McSweeney在12月7日星期三的一笔交易中出售了450股该公司股票。这些股票的平均价格为542.30美元，总价值为244,035.00美元。出售股份后，执行副总裁总裁现在直接持有该公司8736股股份，价值约4737532.80美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过此超链接。公司内部人士目前持有该公司0.40%的股份。
Institutional Trading of UnitedHealth Group
UnitedHealth Group的机构交易
A number of hedge funds have recently modified their holdings of UNH. TimeScale Financial Inc. raised its holdings in UnitedHealth Group by 276.9% during the 3rd quarter. TimeScale Financial Inc. now owns 49 shares of the healthcare conglomerate's stock worth $25,000 after buying an additional 36 shares during the period. Pflug Koory LLC raised its holdings in UnitedHealth Group by 160.0% during the 3rd quarter. Pflug Koory LLC now owns 52 shares of the healthcare conglomerate's stock worth $26,000 after buying an additional 32 shares during the period. Urban Wealth Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth approximately $29,000. Knott David M Jr acquired a new stake in UnitedHealth Group during the 2nd quarter worth approximately $29,000. Finally, Belmont Capital LLC grew its stake in shares of UnitedHealth Group by 294.1% during the 3rd quarter. Belmont Capital LLC now owns 67 shares of the healthcare conglomerate's stock worth $34,000 after acquiring an additional 50 shares in the last quarter. 86.31% of the stock is currently owned by institutional investors and hedge funds.
一些对冲基金最近调整了对UNH的持股。Timescale Financial Inc.在第三季度将其在UnitedHealth Group的持股增加了276.9%。Timescale Financial Inc.现在持有这家医疗保健集团49股股票，价值25,000美元，在此期间又购买了36股。Pflug Koory LLC在第三季度将其在UnitedHealth Group的持股增加了160.0%。Pflug Koory LLC现在持有这家医疗保健集团52股股票，价值2.6万美元，在此期间又购买了32股。Urban Wealth Management LLC在第二季度收购了UnitedHealth Group的新股份，价值约2.9万美元。诺特David M Jr在第二季度收购了UnitedHealth Group的新股份，价值约29,000美元。最后，贝尔蒙资本有限责任公司在第三季度将其在联合健康集团的股份增加了294.1%。Belmont Capital LLC在上个季度增持了50股后，现在持有这家医疗保健集团67股股票，价值3.4万美元。86.31%的股票目前由机构投资者和对冲基金持有。
About UnitedHealth Group
UnitedHealth Group简介
(Get Rating)
(获取评级)
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
UnitedHealth Group，Inc.致力于提供医疗保健覆盖、软件和数据咨询服务。它通过以下细分市场运作：UnitedHealthcare、OpumHealth、OpumInsight和OpumRx。UnitedHealthcare部门利用Optus的能力来帮助协调患者护理、提高医疗负担能力、分析成本趋势、管理药房福利、更有效地与护理提供者合作，以及创建更简单的消费者体验。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 免费获取StockNews.com关于UnitedHealth Group(UNH)的研究报告
- 市场回顾周-1/23-1/27
- 为什么Lucid在一天内飙升了近100%
- 利用这些铁路股票实现增长和收入
- ASML预计今年芯片需求回升，提振销售观点
- KLA公司：在动荡不安的半市场中站稳脚跟
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受UnitedHealth Group Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对UnitedHealth Group和相关公司的最新新闻和分析师评级的每日简要摘要。